首页> 外国专利> Method of using estrogen-related receptor gamma (ERRgamma) status to determine prognosis and treatment strategy for breast cancer, method of using ERRgamma as a therapeutic target for treating breast cancer, method of using ERRgamma to diagnose breast cancer, and method of using ERRgamma to identify individuals predisposed to breast cancer

Method of using estrogen-related receptor gamma (ERRgamma) status to determine prognosis and treatment strategy for breast cancer, method of using ERRgamma as a therapeutic target for treating breast cancer, method of using ERRgamma to diagnose breast cancer, and method of using ERRgamma to identify individuals predisposed to breast cancer

机译:利用雌激素相关受体γ(ERRgamma)状态确定乳腺癌的预后和治疗策略的方法,以ERRgamma作为治疗乳腺癌的治疗靶标的方法,使用ERRgamma诊断乳腺癌的方法以及将ERRgamma用于诊断乳腺癌的方法识别易患乳腺癌的个体

摘要

The present invention provides that ERR is both a breast cancer biomarker and a breast cancer treatment target. A high ERR level in breast cancer cells indicates good prognosis. A high level of ERR in breast tissue suspected of being cancerous is indicative of breast cancer. Analyzing ERR status and optionally along with the status of ER can help breast cancer patients make treatment choices. Furthermore, breast cancer can be treated by decreasing ERR activity in breast cancer cells.
机译:本发明提供了ERR既是乳腺癌生物标志物又是乳腺癌治疗靶标。乳腺癌细胞中较高的ERR水平表明预后良好。怀疑是癌的乳腺组织中高水平的ERR表示乳腺癌。分析ERR状态以及可选地与ER状态一起分析可以帮助乳腺癌患者做出治疗选择。此外,可以通过降低乳腺癌细胞中的ERR活性来治疗乳腺癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号